Testing effectiveness (Phase 2)Study completedNCT00089349
What this trial is testing
Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
Who this might be right for
Recurrent Childhood Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 25